IDEXX LABORATORIES INC /DE (IDXX) Share-based Payment Arrangement, Expense USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Idexx Laboratories Inc /De quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Idexx Laboratories Inc /De Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $14.4 M, a 3.6% increase year-over-year.
  • Idexx Laboratories Inc /De Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $60.2 M, a 14.8% increase year-over-year.
  • Idexx Laboratories Inc /De annual Share-based Payment Arrangement, Expense for 2023 was $59.7 M, a 20% increase from 2022.
  • Idexx Laboratories Inc /De annual Share-based Payment Arrangement, Expense for 2022 was $49.8 M, a 31.8% increase from 2021.
  • Idexx Laboratories Inc /De annual Share-based Payment Arrangement, Expense for 2021 was $37.8 M, a 22% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $60.2 M $14.4 M +$500 K +3.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $59.7 M $15.2 M +$1.87 M +14% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $57.9 M $15.2 M +$2.3 M +17.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $55.6 M $15.4 M +$3.1 M +25.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $52.5 M $13.9 M +$2.7 M +24.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $49.8 M $13.4 M +$3.62 M +37.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $46.2 M $12.9 M +$3.4 M +35.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $42.8 M $12.3 M +$2.7 M +28.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $40.1 M $11.2 M +$2.3 M +25.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $37.8 M $9.76 M +$1.8 M +22.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $36 M $9.5 M +$1.6 M +20.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $34.4 M $9.6 M +$1.8 M +23.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $32.6 M $8.9 M +$1.6 M +21.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $31 M $7.95 M -$8.73 M -52.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $39.7 M $7.9 M -$1.5 M -16% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $41.2 M $7.8 M +$900 K +13% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $40.3 M $7.3 M +$1 M +15.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $39.3 M $16.7 M +$10.5 M +171% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $28.8 M $9.4 M +$2.9 M +44.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $25.9 M $6.9 M +$400 K +6.15% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $25.5 M $6.3 M +$300 K +5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $25.2 M $6.16 M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $6.5 M +$400 K +6.56% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $6.5 M +$500 K +8.33% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $6 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q3 2017 $6.1 M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $6 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.